Literature DB >> 1372375

Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival.

R Izumi1, K Shimizu, M Kiriyama, T Hashimoto, M Urade, M Yagi, Y Mizukami, A Nonomura, I Miyazaki.   

Abstract

Immunohistochemistry using the avidin-biotin-peroxidase complex method was performed to study the production of alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC) tissue specimens which were obtained surgically. The relationship between staining for AFP and serum AFP levels or pathological findings was examined. The prognosis of the patients with HCC who underwent curative hepatic resections was studied with respect to the staining for AFP in their tumors. The mean serum AFP level in patients with positive AFP staining was significantly higher than in those with negative AFP staining. No significant relationship was found between AFP positivity and tumor size, tumor encapsulation, degree of vascular invasion, or the histological differentiation grade of the tumor. The patients with AFP-positive carcinomas had a poorer prognosis than did those with AFP-negative carcinomas (5-year survival rate of AFP-positive and negative groups were 26.7% and 56.5%, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372375     DOI: 10.1002/jso.2930490305

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

1.  Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer.

Authors:  Mark J Hoenerhoff; Arun R Pandiri; Stephanie A Lahousse; Hu-Hua Hong; Tai-Vu Ton; Tiwanda Masinde; Scott S Auerbach; Kevin Gerrish; Pierre R Bushel; Keith R Shockley; Shyamal D Peddada; Robert C Sills
Journal:  Toxicol Pathol       Date:  2011-05-13       Impact factor: 1.902

2.  Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma.

Authors:  Gia L Tyson; Zhigang Duan; Jennifer R Kramer; Jessica A Davila; Peter A Richardson; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2011-08-04       Impact factor: 11.382

3.  Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation.

Authors:  Nestor F Esnaola; Gregory Y Lauwers; Nadeem Q Mirza; David M Nagorney; Dorota Doherty; Iwao Ikai; Yoshio Yamaoka; Jean Marc Regimbeau; Jacques Belghiti; Steven A Curley; Lee M Ellis; J Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

4.  Cirrhosis and Chronic Viral Hepatitis as Risk Factors for Hepatocellular Carcinoma: Romanian Single-clinic Experience.

Authors:  Cristin Vere Constantin; Costin Teodor Streba; Ion Rogoveanu; Liliana Nita-Stefanescu; Alin Gabriel Ionescu
Journal:  Maedica (Buchar)       Date:  2010-12

5.  Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.

Authors:  Xiao-Yong Fu; Hong-Yang Wang; Lu Tan; Shu-Qin Liu; Hui-Fang Cao; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 6.  Natural history of hepatitis-related hepatocellular carcinoma.

Authors:  David-Yiu-Kuen But; Ching-Lung Lai; Man-Fung Yuen
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

7.  Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma.

Authors:  Laura E Moreno-Luna; Oscar Arrieta; Jorge García-Leiva; Braulio Martínez; Aldo Torre; Misael Uribe; Eucario León-Rodríguez
Journal:  BMC Cancer       Date:  2005-10-31       Impact factor: 4.430

8.  A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination.

Authors:  L G Ahronian; L J Zhu; Y-W Chen; H-C Chu; D S Klimstra; B C Lewis
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

9.  The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  Oscar Arrieta; Bernardo Cacho; Daniela Morales-Espinosa; Ana Ruelas-Villavicencio; Diana Flores-Estrada; Norma Hernández-Pedro
Journal:  BMC Cancer       Date:  2007-02-08       Impact factor: 4.430

10.  Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma.

Authors:  Zhiguo Zhang; Yanying Zhang; Yeying Wang; Lingling Xu; Wanju Xu
Journal:  Onco Targets Ther       Date:  2015-12-31       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.